St. Gregory Retreat Center Uses Brain Resource’s MyBrainSolutions-Clinical Tools For Addiction Recovery

Brain Resource, Inc., (OTCBB:BRRZY) (ASX:BRC), developer of innovative cognitive assessments and tools to improve brain health, announced today that St. Gregory Retreat Center will begin using MyBrainSolutions-Clinical, which combines the company’s MyBrainSolutions and WebNeuro products.

MyBrainSolutions-Clinical will help assess patients’ cognitive and emotional capacities, and offer online brain exercises to enhance thinking, self-regulation and personal resiliency. St. Gregory, located in Des Moines, Iowa, utilizes cognitive behavior therapy, neurocognitive therapy, behavior modification training and other evidence-based elements as part of its chemical dependency recovery programs.

“Numerous studies have suggested cognitive training can improve brain processing deficits associated with mental health conditions. Our tools will work hand-in-hand with the St Gregory Recovery Program © to address cognitive aspects of an individual’s recovery,” said Gregory A. Bayer, Ph.D., Chief Executive Officer of Brain Resource, Inc. “We are excited to partner with St. Gregory as our assessment and personalized online cognitive training programs will assist patients in reestablishing confidence in their cognitive skills, promote stress reduction and improve resiliency.”

MyBrainSolutions-Clinical incorporates Brain Resource’s WebNeuro, a clinically validated tool for objective assessment of core cognitive strengths and weaknesses in addition to emotional capacities. Backed by the world’s largest brain database, the WebNeuro assessment is delivered online and instantly so that St. Gregory counselors will be able to profile and track each patient’s cognitive capacity as they progress in recovery. The company’s MyBrainSolutions, a scientifically designed, online brain health solution used to know and train the brain for peak performance, will provide each patient with a tailored program of brain exercises to address each patient’s unique needs.

“Cognitive processing is particularly important when treating patients with addictions as it could directly relate to the underlying causes of dependency,” said Michael Vasquez, Chief Executive Officer of St. Gregory. “As an organization that emphasizes the importance of cognitive therapy, we believe the use of MyBrainSolutions-Clinical will provide additional support to our patients, potentially preventing future relapses and resulting in a more thorough and healthy reclamation of our patient’s lives.”

Brain Resource is exhibiting at the upcoming National Council’s Mental Health and Addictions Conference in Chicago from April 15-17, 2012 at booth #1108. Additionally, the company will be attending the American Telemedicine Association 2012 Annual International Meeting & Exposition from April 29 - May 1, 2012 in San Jose, Calif.

To learn more about WebNeuro and MyBrainSolutions, visit Brain Resource’s website and follow the conversation on Twitter.

About Brain Resource, Inc.

Brain Resource, Inc. (BRRZY: OTC US, BRC: ASX) translates new findings about the brain into engaging products for consumers, employers and clinicians to improve cognition and brain function. With offices in San Francisco and Australia, and agents in Europe and Israel, the company is underpinned by an international consortium of scientists and clinicians that bring together all aspects about the brain that are usually assessed independently. For more information, follow Brain Resource on Twitter @MyBrainSolution or visit

About St. Gregory Centers, Inc

St. Gregory ( is a provider of proprietary substance abuse treatment services. The company offers a unique and highly differentiated treatment program that utilizes behavior modification, cognitive training and health wellness to achieve superior treatment outcomes (with no meetings) relative to other existing treatment modalities. The only program of its type in America that delivers all of these proprietary services integrated into a single delivery model, St. Gregory serves patients across the U.S. 888-778-5833.

Copyright Business Wire 2010